Why Merck Just Slashed Its Profit Outlook By Nearly 50%
Merck cuts FY2026 adjusted EPS outlook nearly in half to $2.66-$2.76, citing $2.43/share in charges from its Terns acquisition.
Merck said it will make much less profit next year because it bought another company called Terns and has to pay big costs from that deal. When a company cuts its profit promises, it's worth watching to see if the Terns business turns out to help them later.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.